Star Imaging And Path Lab: CERC Selects Co For Medical Services
Star Imaging And Path Lab Limited has been empaneled by the Central Electricity Regulatory Commission (CERC) to provide medical diagnostic and laboratory services for a three-year period. The empanelment covers comprehensive medical services for CERC officers, employees, and their dependent family members at CGHS approved rates, representing a stable government sector contract for the healthcare company.
*this image is generated using AI for illustrative purposes only.
Star Imaging And Path Lab Limited has announced its empanelment with the Central Electricity Regulatory Commission (CERC) for providing medical diagnostic and laboratory services. The company disclosed this development on January 14, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Empanelment Details
The empanelment allows Star Imaging And Path Lab Limited to provide comprehensive medical services to CERC's workforce and their families. The scope of services includes medical treatment, diagnosis, and laboratory services for CERC officers, employees, and their dependent family members.
| Parameter: | Details |
|---|---|
| Empanelling Authority: | Central Electricity Regulatory Commission (CERC) |
| Service Scope: | Medical diagnostic and laboratory services |
| Beneficiaries: | Officers, employees, and dependent family members |
| Pricing Structure: | CGHS approved rates |
| Validity Period: | Three years from empanelment letter date |
Service Framework
The empanelment operates under the Central Government Health Scheme (CGHS) approved rate structure, ensuring standardized pricing for the medical services provided. This framework covers a comprehensive range of medical diagnostic and laboratory services that will be available to the eligible beneficiaries under the CERC empanelment.
Regulatory Compliance
The company has emphasized that this empanelment disclosure is made in the ordinary course of business and does not constitute a material event impacting the company's financial position. The announcement serves primarily as a matter of regulatory compliance and transparency, fulfilling the company's obligations under SEBI listing regulations.
Business Impact
While the company has stated that this empanelment does not represent a material financial event, it demonstrates Star Imaging And Path Lab Limited's capability to secure government sector contracts for medical diagnostic services. The three-year validity period provides a stable service arrangement with CERC, potentially contributing to the company's healthcare service portfolio expansion.
Historical Stock Returns for Star Imaging And Path Lab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.80% | +0.79% | -21.05% | -36.96% | -36.96% | -36.96% |
18
